Business
CardioComm Solutions to Develop Full Body, Multiple-Biosignal Remote Patient Monitoring Solutions
New health monitoring device integrations, including wearables, and new software releases will...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions to Develop Full Body, Multiple-Biosignal Remote Patient Monitoring SolutionsNew health monitoring device integrations, including wearables, and new software releases will support medical and consumer wearable market demand for credible patient monitoring solutionsToronto, Ontario--(Newsfile Corp. - November 4, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm\" or the \"Company\"), a global medical provider of consumer heart monitoring and medical electrocardiogram (\"ECG\") software solutions, announces that it has begun work on a medical multiple biosignal monitoring platform that will support remote patient monitoring (\"RPM\") and telemedicine needs, including the use of wearable devices such as patches and wrist worn devices.CardioComm recently secured an expanded ISO 13485:2016 MDSAP certification that permits the Company to grow its operations solely from the development and sales of cardiac ECG monitoring software, hardware and ECG reading services, to now include multiple health monitoring signals such as blood pressure, temperature, weight and P02. The Company is a trusted provider of ECG monitoring solutions to hospitals, physician offices and remote patient monitoring service providers. CardioComm is unique in its use of hospital ECG software in its consumer ECG product offerings that are sold under the HeartCheck™ brand and SMART Monitoring ECG reading services. The expansion into offering a platform with hardware and reviewing services for whole body biosignal monitoring is a logical progression.CardioComm's platform will address the need for adherence to critical characteristics absent in many remote patient monitoring solutions offered today. These include, and are not limited to, compliance to a recognized quality management system and ideally to the medical ISO 13485:2016 standard, a use of devices that are cleared as medical devices for consumer use or under prescription use. This will ensure communication from multiple Bluetooth connected devices are secure and that the whole platform supporting RPM is scalable and can support secure data collection and data processing from thousands of monitored lives in near-real time. CardioComm will provide updates on the new platform including expected FDA and Health Canada clearance applications for new health monitoring devices th...